IT Versione italiana

up-dating events » Scientific Symposium at EAU Congress, sponsored by IBSA

Increasing evidence of effectiveness of GAG therapy in different forms of cystitis

Glycosaminoglycan (GAG) therapy is now being studied for the treatment of a wide variety of acquired and inherited diseases in different therapeutic areas, including bladder disorders such as urinary tract infections,painful bladder syndrome/interstitial cystitis,cystitis following radiation therapy or chemical agents. The positive outcomes obtained with a combination of hyaluronic acid and chondroitin sulphate administered intravesically in patients with an history of bladder damage, with the aim of restoring the integrity of the glycosaminoglycan layer of the urothelium, suggest that such therapeutic approach might be beneficial. A faculty of experts will review the results of the recent clinical investigations with this GAG combination and discuss its therapeutic applications.


Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK